SCHEMBL10016653

SCHEMBL10016653

CCCCCCC/C=C/C(=O)N(CCCN(C)C)CCCN(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.44
PPARA Q07869 3/20 0.44
DNM1 Q05193 3/20 0.44
EPHX2 P34913 3/20 0.43
ZDHHC20 Q5W0Z9 1/20 0.42
TERT O14746 3/20 0.42
MAPT P10636 2/20 0.42
BLM P54132 2/20 0.42
HSD17B10 Q99714 2/20 0.42
FABP4 P15090 2/20 0.42
GMNN O75496 1/20 0.42
USP2 O75604 1/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
POLB P06746 1/20 0.42
CYP2C9 P11712 1/20 0.42
ALOX15 P16050 1/20 0.42
APEX1 P27695 1/20 0.42
CYP2C19 P33261 1/20 0.42
RECQL P46063 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15204996 1.00 PPARG (0.44) PPARGPPARADNM1EPHX2ZDHHC20
SCHEMBL15205394 0.92 PPARG (0.45) PPARGPPARAEPHX2TERTMAPT
SCHEMBL10016646 0.92 PPARG (0.45) PPARGPPARAEPHX2TERTMAPT
SCHEMBL15205175 0.90 ZDHHC20 (0.50) PPARGPPARAEPHX2ZDHHC20TERT
SCHEMBL10016662 0.90 ZDHHC20 (0.50) PPARGPPARAEPHX2ZDHHC20TERT
SCHEMBL28066861 0.90 ZDHHC20 (0.50) PPARGPPARAEPHX2ZDHHC20TERT
SCHEMBL15216629 0.90 PPARG (0.49) PPARGPPARAZDHHC20TERTMAPT
SCHEMBL27992461 0.90 PPARG (0.49) PPARGPPARAZDHHC20TERTMAPT
SCHEMBL8036393 0.90 ZDHHC20 (0.50) PPARGPPARAEPHX2ZDHHC20TERT
SCHEMBL10016640 0.90 ZDHHC20 (0.50) PPARGPPARAEPHX2ZDHHC20TERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2636666-B1 TRANS-2-DECENOIC ACID DERIVATIVE AND MEDICAMENT CONTAINING SAME NAGOYA INDUSTRIAL SCIENCE RES INSTITUTE (JP) 2018-01-10 EP disclosed
US-20150297562-A1 ANALGESIC NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2015-10-22 US disclosed
US-20150297562-A1 ANALGESIC NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2015-10-22 US disclosed
US-20150297562-A1 ANALGESIC NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2015-10-22 US disclosed
US-8987486-B2 Trans-2-decenoic acid derivative and pharmaceutical agent containing the same NAGOYA INDUSTRIAL SCIENCE RESEARCH INSTITUTE (JP) 2015-03-24 US disclosed
US-8987486-B2 Trans-2-decenoic acid derivative and pharmaceutical agent containing the same NAGOYA INDUSTRIAL SCIENCE RESEARCH INSTITUTE (JP) 2015-03-24 US disclosed
US-8987486-B2 Trans-2-decenoic acid derivative and pharmaceutical agent containing the same NAGOYA INDUSTRIAL SCIENCE RESEARCH INSTITUTE (JP) 2015-03-24 US disclosed
EP-2842553-A1 ANALGESIC Nippon Zoki Pharmaceutical Co., Ltd. (JP) 2015-03-04 EP disclosed
EP-2842553-A1 ANALGESIC Nippon Zoki Pharmaceutical Co., Ltd. (JP) 2015-03-04 EP disclosed
EP-2636666-A1 TRANS-2-DECENOIC ACID DERIVATIVE AND MEDICAMENT CONTAINING SAME Nagoya Industrial Science Research Institute (JP) 2013-09-11 EP disclosed
EP-2636666-A1 TRANS-2-DECENOIC ACID DERIVATIVE AND MEDICAMENT CONTAINING SAME Nagoya Industrial Science Research Institute (JP) 2013-09-11 EP disclosed
US-20130225837-A1 TRANS-2-DECENOIC ACID DERIVATIVE AND PHARMACEUTICAL AGENT CONTAINING THE SAME NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2013-08-29 US disclosed
US-20130225837-A1 TRANS-2-DECENOIC ACID DERIVATIVE AND PHARMACEUTICAL AGENT CONTAINING THE SAME NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2013-08-29 US disclosed
US-20130225837-A1 TRANS-2-DECENOIC ACID DERIVATIVE AND PHARMACEUTICAL AGENT CONTAINING THE SAME NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2013-08-29 US disclosed
WO-2012060396-A1 TRANS-2-DECENOIC ACID DERIVATIVE AND MEDICAMENT CONTAINING SAME 財団法人名古屋産業科学研究所 (JP) 2012-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150297562-A1 ANALGESIC OPRK1, OPRL1, OPRD1 PPARG 1209/4885PPARA 757/4885DNM1 4508/4885
US-20130225837-A1 TRANS-2-DECENOIC ACID DERIVATIVE AND PHARMACEUTICAL AGENT CONTAINING THE SAME BDNF, NTRK2, NGF PPARG 1310/4885PPARA 1112/4885DNM1 3712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.